CLINICAL TRIALS PROFILE FOR LACTULOSE
✉ Email this page to a colleague
All Clinical Trials for Lactulose
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00004796 ↗ | Phase II Study of Lactulose and Circadian Rhythms in Patients With Cirrhosis | Completed | Northwestern University | Phase 2 | 1994-11-01 | OBJECTIVES: I. Assess the effect of lactulose on the circadian rhythm of plasma melatonin in patients with subclinical hepatic encephalopathy. II. Assess the intrasubject variability of circadian melatonin levels and neuropsychological tests. III. Assess which elements of the neuropsychological test battery show the response to lactulose. |
| NCT00004796 ↗ | Phase II Study of Lactulose and Circadian Rhythms in Patients With Cirrhosis | Completed | National Center for Research Resources (NCRR) | Phase 2 | 1994-11-01 | OBJECTIVES: I. Assess the effect of lactulose on the circadian rhythm of plasma melatonin in patients with subclinical hepatic encephalopathy. II. Assess the intrasubject variability of circadian melatonin levels and neuropsychological tests. III. Assess which elements of the neuropsychological test battery show the response to lactulose. |
| NCT00133406 ↗ | Long-term Impact and Intervention for Diarrhea in Brazil | Unknown status | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 3 | 2006-06-01 | The primary objectives of this study are to determine the effect of 1 year supplementation of Vitamin A, Zinc, and Vitamin A plus Zinc compared to placebo on the Height for Age Z Score (HAZ) and the number of episodes of diarrhea and number of days of diarrhea at one year in children living in a Brazilian slum. Study participants will include 280 children ages 2 months to 8 years old, with a Height for Age Z score (HAZ) less than median for the Parque Universitario community, living in Brazilian favela. There is also a sub study to determine if ten days of glutamine delivered as an oral bolus improves the health of the digestive system. |
| NCT00133406 ↗ | Long-term Impact and Intervention for Diarrhea in Brazil | Unknown status | University of Virginia | Phase 3 | 2006-06-01 | The primary objectives of this study are to determine the effect of 1 year supplementation of Vitamin A, Zinc, and Vitamin A plus Zinc compared to placebo on the Height for Age Z Score (HAZ) and the number of episodes of diarrhea and number of days of diarrhea at one year in children living in a Brazilian slum. Study participants will include 280 children ages 2 months to 8 years old, with a Height for Age Z score (HAZ) less than median for the Parque Universitario community, living in Brazilian favela. There is also a sub study to determine if ten days of glutamine delivered as an oral bolus improves the health of the digestive system. |
| NCT00133562 ↗ | HIAS II - Study of Nutritional Supplementation in Hospitalized Children With Persistent Diarrhea or Malnutrition | Withdrawn | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 3 | 2004-08-01 | This study will determine the effect of 7 days supplementation of alanyl-glutatime or glycine on the damaged intestinal barrier function on day 8 in children with persistent diarrhea or malnutrition. |
| NCT00133562 ↗ | HIAS II - Study of Nutritional Supplementation in Hospitalized Children With Persistent Diarrhea or Malnutrition | Withdrawn | University of Virginia | Phase 3 | 2004-08-01 | This study will determine the effect of 7 days supplementation of alanyl-glutatime or glycine on the damaged intestinal barrier function on day 8 in children with persistent diarrhea or malnutrition. |
| NCT00160264 ↗ | Study to Investigate if Adding Lactulose to Vitamin D and Calcium Has an Effect on the Preservation of Bone in Postmenopausal Women | Completed | Solvay Pharmaceuticals | Phase 4 | 2003-01-01 | This is a randomized, double-blind, multicentre, parallel pilot clinical trial to study the efficacy of a treatment of lactulose 15 ml + vitamin D 400 U + calcium 0.5 g compared to lactulose placebo 15 ml + vitamin D 400 U + calcium 1 g in bone mass preservation among postmenopausal women. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Lactulose
Condition Name
Clinical Trial Locations for Lactulose
Trials by Country
Clinical Trial Progress for Lactulose
Clinical Trial Phase
Clinical Trial Sponsors for Lactulose
Sponsor Name
